# FDA Inspection 1270105 - Boston University National Emerging Infectious Disease Laboratories - May 16, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/boston-university-national-emerging-infectious-disease-laboratories/6db4b029-7591-4d65-bae0-9d3af5a3c889
Source feed: FDA_Inspections

> FDA Inspection 1270105 for Boston University National Emerging Infectious Disease Laboratories on May 16, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1270105
- Company Name: Boston University National Emerging Infectious Disease Laboratories
- Inspection Date: 2025-05-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1270105 - 2025-05-16](https://www.globalkeysolutions.net/records/fda_inspections/boston-university-national-emerging-infectious-disease-laboratories/a7a03302-9183-470e-bc07-82acd74c6e4c)

Company: https://www.globalkeysolutions.net/companies/boston-university-national-emerging-infectious-disease-laboratories/050558e2-09bc-4c20-856b-d9bbdf2a9300

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c